Sunesis Pharmaceuticals (SNSS) Posts Smaller-than-Expected Q2 Loss
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Other income (expense), net: 23K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Other income (expense), net: 23K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q2 EPS of ($0.41), $0.18 better than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- XP Inc eyes US banking license as next business step
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
